PAP
TNGX icon

Persistent Asset Partners’s Tango Therapeutics TNGX Stock Holding History

Persistent Asset Partners’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-461
Closed -$55.4K – 305
2025
Q2 		$55.4K Buy
+461
New +$1.14K 0.04% 145

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Persistent Asset Partners's TNGX Position: Q2 2026 in Review

Persistent Asset Partners reduced its Tango Therapeutics (TNGX) stake by 64% in Q2 2026, selling an estimated $368K and leaving 8,238 shares worth $258K. The position accounts for 0.08% of the portfolio, ranked #179.

Persistent Asset Partners first reported a position in TNGX in Q1 2026 and has held it in 2 quarters since. The position peaked at $484K in Q1 2026. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Persistent Asset Partners held 8,238 shares of Tango Therapeutics worth $258K as of Q2 2026.
  • Persistent Asset Partners sold 14,878 Tango Therapeutics shares in Q2 2026, an estimated $368K.
  • Tango Therapeutics made up 0.08% of Persistent Asset Partners's portfolio in Q2 2026, its #179 holding.
  • Persistent Asset Partners first reported a position in Tango Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Persistent Asset Partners's Tango Therapeutics position peaked at $484K in Q1 2026.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.